Abstract
Malaria incidence has declined dramatically over the past decade and China was certified malaria-free in 2021. However, the presence of malaria in border areas and the importation of cases of malaria parasites are major challenges for the consolidation of the achievements made by China. Plasmodium vivax Duffy binding protein (PvDBP) performs a significant role in erythrocyte invasion, and is considered a promising P. vivax vaccine. However, the highly polymorphic region of PvDBP (PvDBP-II) impedes the development of blood-stage vaccine against P. vivax. In this study, we investigated the genetic diversity and natural selection of PvDBP-II among 124 P. vivax isolates collected from the China-Myanmar border (CMB) in Yunnan Province, China, during 2009–2011. To compare genetic diversity, natural selection, and population structure with CMB isolates, 85 pvdbp-II sequences of eastern Myanmar isolates were obtained from GenBank. In addition, global sequences of pvdbp-II were retrieved from GenBank to establish genetic differentiation relationships and networks with the CMB isolates. In total, 22 single nucleotide polymorphisms reflected in 20 non-synonymous and two synonymous mutations were identified. The overall nucleotide diversity of PvDBP-II from the 124 CMB isolates was 0.0059 with 21 haplotypes identified (Hd = 0.91). The high ratio of non-synonymous to synonymous mutations suggests that PvDBP-II had evolved under positive selection. Population structure analysis of the CMB and eastern Myanmar isolates were optimally grouped into five sub-populations (K = 5). Polymorphisms of PvDBP-II display that CMB isolates were genetically diverse. Mutation, recombination, and positive selection promote polymorphism of PvDBP-II of P. vivax population. Although low-level genetic differentiation in eastern Myanmar was identified along with the more effective malaria control measures, the complexity of population structure in malaria parasites has maintained. In conclusion, findings from this study advance knowledge of the understanding of the dynamic of P. vivax population, which will contribute to guiding the rational design of a PvDBP-II based vaccine.
Highlights
Malaria, a common and life-threatening infectious disease, affects 2.29 billion people worldwide
Comparison of the amino variants observed in PvDBPII revealed that ChinaMyanmar border (CMB) isolates had a similar pattern compared to eastern Myanmar isolates
PvdbpII of CMB isolates bear some diversity, it is noteworthy that the prevalent Haplotype 4 (12.7%) was shared with multiple populations, which may present an attractive point for vaccine development. This investigation provided the description of genetic polymorphism and natural selection of pvdbp-II in the CMB of Yunnan Province during 2009–2011
Summary
A common and life-threatening infectious disease, affects 2.29 billion people worldwide. Myanmar has the highest malaria burden in the GMS, with a major challenge for disease control and elimination, especially to neighboring countries such as China (Yunnan and Guangxi Provinces) and Thailand (Lo et al, 2017; Brashear et al, 2020). The ChinaMyanmar border (CMB) was once the area where the burden of malaria was highest in the world. China has been certified malaria-free in 2021, the country is still cautious about imported cases and malaria retransmission. Malaria control in the CMB area is a challenge owing to the high prevalence of malaria in Myanmar, resulting in continuous transmission and infection (Feng et al, 2020). Cases of imported malaria pose a threat for sustainable malaria-free status within the borders of China. With the progress in the implementation of malaria elimination measures, it is reasonable to speculate whether there was a change in P. vivax population structure
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
